Uniphar (LON:UPR) Trading Down 2.4% – Time to Sell?

Uniphar plc (LON:UPR)’s share price fell 2.4% during mid-day trading on Tuesday . The company traded as low as GBX 182.18 ($2.34) and last traded at GBX 183.50 ($2.36). 8,571 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 37,913 shares. The stock had previously closed at GBX 188 ($2.42).

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 310 ($3.99) price target on shares of Uniphar in a research report on Wednesday, September 4th.

Uniphar Trading Down 2.4 %

The company has a quick ratio of 0.60, a current ratio of 0.90 and a debt-to-equity ratio of 119.43. The business’s fifty day moving average is GBX 210.32 and its two-hundred day moving average is GBX 215.16. The firm has a market cap of £500.99 million, a price-to-earnings ratio of 1,310.71 and a beta of 0.75.

Uniphar Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, October 4th. Stockholders of record on Thursday, September 12th were given a dividend of €0.01 ($0.01) per share. The ex-dividend date was Thursday, September 12th. This represents a dividend yield of 0.25%. Uniphar’s payout ratio is currently 1,428.57%.

Uniphar Company Profile

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.